Table 5. Fraction of HPV 6, 11, 16, 18 costs attributable to men.

	Conditions	HPV 6,11,16,18 costs (mill Euro)	Lower bound	Upper bound	Percentage prevalence in men	HPV 6,11,16,18 costs attributable to men (mill Euro)	Lower bound	Upper bound	References
		a	b	c	d	a × d	b × d	c × d
e	Anal cancer	€ 6.7	€ 3.7	€ 9.2	40%	€ 2.7	€ 1.5	€ 3.7	[26]
f	Head and neck cancer	€ 59.1	€ 55.3	€ 60.9	80%	€ 47.3	€ 44.3	€ 48.8	[26]
g	Penile cancer	€ 2.0	€ 1.4	€ 2.5	100%	€ 2.0	€ 1.4	€ 2.5	[26]
h	Anogenital warts (men)	€ 33.8	€ 33.8	€ 33.8	100%	€ 33.8	€ 33.8	€ 33.8	[19]
i	RRP ‡	€ 38.6	€ 38.6	€ 45.5	70%	€ 27.0	€ 27.0	€ 31.8	[7], [8]
l	Total costs attributable to men (e + f + g + h + i)	€ 183.7	€ 176.3	€ 200.1		€ 112.9	€ 108.0	€120.6
	% of non-cervical HPV 6, 11, 16, 18 burden					60.6%	58.0%	64.7%
	% of total HPV 6, 11, 16, 18 burden					38.8%	37.1%	41.4%

^‡Respiratory recurrent papillomatosis (RRP).